Hi NZ,
Just a slight counter view: the board seems pretty switched on; if they had other near-term deals/developments in the wings that they thought would drive greater awareness and market cap growth compared to, for example. a front-page HC ad, do you reckon that they would focus and put their energy into that instead?
I agree these results need to be screamed from the top floor, and normally, an Aus biotech would do so, but the lack of proactive marketing etc, is interesting.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-577
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $82.32M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.8¢ | $51.18K | 269.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 150263 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 243211 | 2 |
View Market Depth
| Last trade - 10.06am 04/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |